CDHA CAAR

September 2, 2021

CAAR – Lancet Oncology Article – September 2, 2021

Filed under: Reports and Articles — Tags: — admin @ 5:49 pm

Note: Check with your organization’s library for availability. “Survival outcomes in older men with non-metastatic castration-resistant prostate cancer treated with androgen receptor inhibitors: a US Food and Drug Administration pooled analysis of patient-level data from three randomised trials,” by Jaleh Fallah, Lijun Zhang, Anup Amatya, Yutao Gong, Bellinda King-Kallimanis, Vishal Bhatnagar, Chana Weinstock, Daniel L. Suzman, Sundeep Agrawal, Elaine Chang, Mitchell S. Anscher, Dow-Chung Chi, James X. Xu, Jamie R. Brewer, Michael H. Brave, Mehrnoosh Hadadi, Marc R. Theoret, Paul G. Kluetz, Kirsten B. Goldberg, Amna Ibrahim, Shenghui Tang, Richard Pazdur, Julia A. Beaver, Laleh Amiri-Kordestani, and Harpreet Singh (Vol. 22, No. 9, September 2021, p. 1230-1239).

www.thelancet.com/journals/lanonc/article/PIIS1470-2045(21)00334-X/fulltext

No Comments

No comments yet.

RSS feed for comments on this post.

Sorry, the comment form is closed at this time.

Powered by WordPress